<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA Pediatrics: Sleep Apnea/Sleep Disorders Topic Collection</title>
    <link>http://archpedi.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Wed, 12 Dec 2012 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 01 Jan 2013 00:52:06 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@archpedi.jamanetwork.com</managingEditor>
    <webMaster>webmaster@archpedi.jamanetwork.com</webMaster>
    <item>
      <title>Early Occurrence of Obstructive Sleep Apnea in Infants and Children With Cystic Fibrosis Cystic Fibrosis and Obstructive Sleep Apnea </title>
      <link>http://archpedi.jamanetwork.com/article.aspx?articleID=1384981</link>
      <pubDate>Sat, 01 Dec 2012 00:00:00 GMT</pubDate>
      <author>Spicuzza L, Sciuto C, Leonardi S, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Objectives&lt;/div&gt;To assess the occurrence of sleep-disordered breathing, hypoxemia, and sleep architecture in a cohort of infants and children with cystic fibrosis (CF) and normal or mildly impaired lung function in stable clinical condition.&lt;div class="boxTitle"&gt;Design&lt;/div&gt;Case-control study.&lt;div class="boxTitle"&gt;Setting&lt;/div&gt;Cystic Fibrosis Unit of a university hospital and pediatric sleep laboratory.&lt;div class="boxTitle"&gt;Participants&lt;/div&gt;A total of 40 children (aged 6 months to 11 years) with CF in stable condition and 18 healthy age-matched control subjects.&lt;div class="boxTitle"&gt;Intervention&lt;/div&gt;Nocturnal sleep and cardiorespiratory monitoring was performed using a full polysomnographic recording in a sleep laboratory.&lt;div class="boxTitle"&gt;Main Outcomes Measures&lt;/div&gt;Sleep architecture and respiratory variables.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;Although awake oxyhemoglobin saturation (SaO&lt;sub&gt;2&lt;/sub&gt;) values were similar in the 2 groups (98%), the CF group had significantly lower values of nocturnal mean SaO&lt;sub&gt;2.&lt;/sub&gt; The apnea-hypopnea index was significantly higher in the CF group compared with the controls (mean [SE], 7.3 [1.3] vs 0.5 [0.4], respectively, P &lt; .001), particularly in preschool-aged children and in children with upper airway abnormalities. In addition, 28 (70%) of the 40 children with CF had mild to moderate obstructive sleep apnea (defined as an apnea-hypopnea index &gt;2). Children with CF compared with controls also had reduced sleep efficiency (CF group vs controls mean [SE], 80% [41%] vs 88% [13.1%], P &lt; .001), rapid eye movement sleep duration (11% [0.9%] vs 13% [1%], P &lt; .05), and increased number of arousals per hour (11.0 [10] vs 8.2 [0.7], P &lt; .001).&lt;div class="boxTitle"&gt;Conclusions&lt;/div&gt;This study showed an early occurrence of obstructive sleep apnea in children with CF in stable condition, associated with a mild level of sleep disruption. Early routine nocturnal respiratory monitoring is advised in children with CF.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">166</prism:volume>
      <prism:number xmlns:prism="prism">12</prism:number>
      <prism:startingPage xmlns:prism="prism">1165</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">1169</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/archpediatrics.2012.1177</prism:doi>
      <guid>http://archpedi.jamanetwork.com/article.aspx?articleID=1384981</guid>
    </item>
  </channel>
</rss>